CHICAGO - Radiation received by other organs during a mammogram is very low and does not present an increased cancer risk, researchers found.
CHICAGO - Mammograms are a fact of life for many women in America. Unfortunately, so are daytime talk shows. When one show suggested that errant radiation from mammograms may cause cancer in other parts of the body, women blanched and doctors cringed.
But a new study presented Tuesday at RSNA 2012 found that radiation received by other organs during a mammogram is very low and does not present an increased cancer risk.
“The risk of cancer to nearby organs is indistinguishable from incidence of cancer due to other sources. The benefits of screening mammography greatly outweigh the scatter radiation to these organs,” said Alison L. Chetlen, DO, who led the study.
Chetlen and colleagues at Penn State Hershey Medical Center set out to study the radiation received by the thyroid, salivary gland, lenses of the eyes, sternum and uterus during a typical mammography and compare it to background radiation that all humans receive simply from living on Earth.
During a mammogram, some X-rays in fact do “scatter” from the beam directed at the breast, she said. While this radiation is weakened, some women became concerned that radiosensitive areas like the thyroid might absorb these extraneous rays and cause cancer later in life. They prefer to wear collars to shield them from the radiation.
As part of the study, 207 women were fitted with six tiny radiation detectors called dosimeters. Smaller than the size of the penny, these detectors measured the amount of ionizing radiation present on the skin while undergoing a two-view mammography screening. The detectors were evaluated by a health physicist and organ dose was calculated based on the skin dose and the average tissue thickness between the skin and the organ.
Researchers found that the average dose received during a screening is miniscule, less than 2 percent than the amount received annually through background radiation.
The absorbed radiation measurements were taken in milligray, mGy. The uterus, for instance, received .002 mGy of radiation during the screening. By comparison, the annual natural background dose is 3.1 millisieverts, mSv, equivalent in this study to mGy. Therefore, “screening mammography can be performed during pregnancy with no increased risk to the fetus,” Chetlen advised.
As for the thyroid, Chetlen posits that thyroid shields are unnecessary and perhaps even detrimental to the mammography process. “The thyroid gland is not radiosensitive in the age group undergoing screening mammography,” she pointed out. “We know that the thyroid collar can get in the way, so much so that if, depending on the heaviness of the patient, it can override the upper inner breast which could obscure significant findings of breast cancer. It could reduce the quality of the image, it may get in the way of the image, causing a shadow or artifact, and we'd have to retake the view.”
Chetlen noted that these are not exact measurements, but more a guideline to be considered by physicians concerning mammography radiation levels.
AI Facilitates Nearly 83 Percent Improvement in Turnaround Time for Fracture X-Rays
December 19th 2023In addition to offering a 98.5 percent sensitivity rate in diagnosing fractures on X-ray, an emerging artificial intelligence (AI) software reportedly helped reduce mean turnaround time on X-ray fracture diagnosis from 48 hours to 8.3 hours, according to new research presented at the Radiological Society of North America (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can an Emerging PET Radiotracer Enhance Detection of Prostate Cancer Recurrence?
December 14th 2023The use of 68Ga-RM2 PET/MRI demonstrated a 35 percent higher sensitivity rate than MRI alone for the diagnosis of biochemical recurrence of prostate cancer, according to research recently presented at the Radiological Society of North America (RSNA) conference.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
Can AI Improve Detection of Extraprostatic Extension on MRI?
December 4th 2023Utilizing a deep learning-based AI algorithm to differentiate between diagnostic and non-diagnostic quality of prostate MRI facilitated a 10 percent higher specificity rate for diagnosing extraprostatic extension on multiparametric MRI, according to research presented at the recent RSNA conference.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.